Literature DB >> 17999832

The white dot syndromes.

Yoko Matsumoto1, Sebastian P Haen, Richard F Spaide.   

Abstract

The white dot syndromes are a heterogeneous group of rare inflammatory disorders affecting the retina, the retinal pigment epithelium, and the choroid. Not all of these diseases actually cause white dots, but they all have unique lesions in the fundus. We describe acute posterior multifocal placoid pigment epitheliopathy, serpiginous choroiditis, birdshot chorioretinopathy, multifocal choroiditis with panuveitis, diffuse subretinal fibrosis syndrome, punctate inner choroidopathy, multiple evanescent white dot syndrome, and diffuse unilateral subacute neuroretinitis as the white dot syndromes in this review. Some of these conditions share an association with systemic infectious diseases. In addition, treatment of these diseases is similar. Some can be treated with immunosuppressive therapy. Other treatment options include laser photocoagulation, topical or systemic steroid therapy, photodynamic therapy, and, most recently, anti-vascular endothelial growth factor agents. The new development in treatment may alter the visual prognosis of the patients, leading to a better outcome in visual acuity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999832

Source DB:  PubMed          Journal:  Compr Ophthalmol Update        ISSN: 1527-7313


  10 in total

Review 1.  Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis.

Authors:  Hossein Nazari Khanamiri; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2013-03-27       Impact factor: 6.048

2.  Fundus autofluorescence imaging: Fundamentals and clinical relevance.

Authors:  Yasir J Sepah; Abeer Akhtar; Mohammad Ali Sadiq; Yamama Hafeez; Humzah Nasir; Brian Perez; Narissa Mawji; Diana J Dean; Daniel Ferraz; Quan Dong Nguyen
Journal:  Saudi J Ophthalmol       Date:  2014-03-24

3.  White dot syndromes: a 20-year study of incidence, clinical features, and outcomes.

Authors:  Nakhleh E Abu-Yaghi; Stella P Hartono; David O Hodge; Jose S Pulido; Sophie J Bakri
Journal:  Ocul Immunol Inflamm       Date:  2011-12       Impact factor: 3.070

4.  Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

Authors:  Nora Mirza; Manfred Zierhut; Andreas Korn; Antje Bornemann; Wichard Vogel; Barbara Schmid-Horch; Wolfgang A Bethge; Stefan Stevanović; Helmut R Salih; Lothar Kanz; Hans-Georg Rammensee; Sebastian P Haen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-10       Impact factor: 11.205

Review 5.  [White dot syndrome].

Authors:  W Göbel
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

6.  Fundus autofluorescence imaging of the white dot syndromes.

Authors:  Steven Yeh; Farzin Forooghian; Wai T Wong; Lisa J Faia; Catherine Cukras; Julie C Lew; Keith Wroblewski; Eric D Weichel; Catherine B Meyerle; Hatice Nida Sen; Emily Y Chew; Robert B Nussenblatt
Journal:  Arch Ophthalmol       Date:  2010-01

Review 7.  Fundus albipunctatus: review of the literature and report of a novel RDH5 gene mutation affecting the invariant tyrosine (p.Tyr175Phe).

Authors:  Anna Skorczyk-Werner; Przemysław Pawłowski; Marta Michalczuk; Alicja Warowicka; Anna Wawrocka; Katarzyna Wicher; Alina Bakunowicz-Łazarczyk; Maciej R Krawczyński
Journal:  J Appl Genet       Date:  2015-03-28       Impact factor: 3.240

Review 8.  Fundus autofluorescence applications in retinal imaging.

Authors:  Andrea Gabai; Daniele Veritti; Paolo Lanzetta
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

Review 9.  Multi-modal imaging and anatomic classification of the white dot syndromes.

Authors:  Meisha L Raven; Alexander L Ringeisen; Yoshihiro Yonekawa; Maxwell S Stem; Lisa J Faia; Justin L Gottlieb
Journal:  Int J Retina Vitreous       Date:  2017-03-20

Review 10.  Role of autofluorescence in inflammatory/infective diseases of the retina and choroid.

Authors:  Ahmed Samy; Sue Lightman; Filis Ismetova; Lazha Talat; Oren Tomkins-Netzer
Journal:  J Ophthalmol       Date:  2014-04-01       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.